Verition Fund Management »

Apogee Therapeutics shares owned by Verition Fund Management

Quarter-by-quarter ownership of Apogee Therapeutics (APGE) shares owned by Verition Fund Management from 13F filings

Historical chart of Verition Fund Management investment in Apogee Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Apogee Therapeutics held by Verition Fund Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Apogee Therapeutics by Verition Fund Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $2.0M 50k 39.73
2024-12-31 $882k 20k 45.30

More positions owned by Verition Fund Management

NVIDIA Corporation (NVDA)
Ishares Tr Core S&p500 Etf (IVV)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Amazon (AMZN)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Ishares Tr Iboxx Hi Yd Etf (HYG)
Eli Lilly & Co. (LLY)
Ishares Tr Iboxx Inv Cp Etf (LQD)
Ishares Bitcoin Trust Etf Shs Ben Int (IBIT)
Warner Bros Discovery Com Ser A (WBD)
Norfolk Southern (NSC)
Cyberark Software SHS (CYBR)
Microsoft Corporation (MSFT)
Apple (AAPL)
Kraneshares Trust Csi Chi Internet Call Option (KWEB)

View all positions for Verition Fund Management

Top funds holding Apogee Therapeutics

VR Adviser
FMR
Wellington Management Company
Rtw Investments
BlackRock
Vanguard Group
Driehaus Capital Management
Fairmount Funds Management
State Street Corporation
Paradigm Biocapital Advisors
Braidwell
Alliancebernstein
Perceptive Advisors
Citadel Advisors
Affinity Asset Advisors

View all funds holding Apogee Therapeutics